会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • TRPV4 ANTAGONISTS
    • WO2012174340A1
    • 2012-12-20
    • PCT/US2012/042603
    • 2012-06-15
    • GLAXOSMITHKLINE LLCBROOKS, CarlCHEUNG, MuiGOODMAN, Krista, B.HAMMOND, Marlys
    • BROOKS, CarlCHEUNG, MuiGOODMAN, Krista, B.HAMMOND, Marlys
    • A61K31/423
    • C07D413/14C07D413/06C07D413/08
    • The present invention relates to spirocarbamate analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists. The TRPV4 antagonist may be administered alone or in conjunction with one or more other therapeutic agents, ego agents being selected from the group consisting of endothelin receptor antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists, vasopeptidase inhibitors, vasopressin receptor modulators, diuretics, digoxin, beta blocker, aldosterone antagonists, iontropes, NSAIDS, nitric oxide donors, calcium channel modulators, muscarinic antagonists, steroidal anti-inflammatory drugs, bronchodilators, anti-histamines, leukotriene antagonist, HMG-CoA reductase inhibitors, dual non-selective padrenoceptor and u1 -adrenoceptor antagonists, type-5 phosphodiesterase inhibitors, and renin inhibitors.
    • 本发明涉及螺氨酸甲酯类似物,含有它们的药物组合物及其作为TRPV4拮抗剂的用途。 TRPV4拮抗剂可以单独给药或与一种或多种其它治疗剂联合施用,所述治疗剂选自由内皮素受体拮抗剂,血管紧张素转换酶(ACE)抑制剂,血管紧张素II受体拮抗剂,血管肽酶抑制剂,加压素受体调节剂 ,利尿剂,地高辛,β阻滞剂,醛固酮拮抗剂,离子诱导剂,NSAIDS,一氧化氮供体,钙通道调节剂,毒蕈碱拮抗剂,甾体抗炎药,支气管扩张剂,抗组胺药,白三烯拮抗剂,HMG-CoA还原酶抑制剂, 选择性受体受体和u1-肾上腺素受体拮抗剂,5型磷酸二酯酶抑制剂和肾素抑制剂。